ChristopherHan ShengChangMD
Gastroenterology • Albuquerque, NMClinical Instructor, Medicine; Digestive Diseases/Gastroenterology, UCLA School of Medicine
Are you Dr. Chang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1501 San Pedro Dr Se
Medicine Service, Box 111
Albuquerque, NM 87108Phone+1 505-265-1711Fax+1 505-256-2803
Summary
- Dr. Christopher Chang, MD is a gastroenterologist in Albuquerque, New Mexico. He is currently licensed to practice medicine in New Mexico, New Jersey, and Delaware. He is affiliated with Raymond G. Murphy Department of Veterans Affairs Medical Center and University of New Mexico Hospitals.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1997 - 2001- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1995 - 1997
University of California San Francisco School of MedicineClass of 1995
Certifications & Licensure
NM State Medical License 2015 - 2025
CA State Medical License 1997 - 2020
DE State Medical License 2010 - 2015
NJ State Medical License 2011 - 2015
PA State Medical License 2010 - 2014
OR State Medical License 1997 - 2013
Publications & Presentations
PubMed
- 1007 citationsReaction-based small-molecule fluorescent probes for chemoselective bioimagingJefferson Y. Chan, Sheel C. Dodani, Christopher J. Chang
Nature Chemistry. 2012-12-01 - 111 citationsMethanobrevibacter smithii Is the Predominant Methanogen in Patients with Constipation-Predominant IBS and Methane on BreathGene Kim, Fnu Deepinder, Walter Morales, Laura Hwang, Stacy Weitsman
Digestive Diseases and Sciences. 2012-05-10 - 175 citationsEpigenetics in Health and Disease.Lian Zhang, Qianjin Lu, Christopher Chang
Advances in Experimental Medicine and Biology. 2020-01-01
Press Mentions
Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human SubjectsMay 13th, 2020
Grant Support
- DFT Investigations Of Mn(Ii/Iii) Oxalate Oxidase ModelsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
